Literature DB >> 16618121

Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.

Alireza R Rezaie1.   

Abstract

It has been demonstrated that a unique pentasaccharide fragment of heparin (H5) activates AT by exposing an exosite on the serpin that is a recognition site for interaction with the basic autolysis loop (residues 143-154) of fXa. In support of this, the substitution of Arg-150 of fXa with Ala (R150A) impaired the reactivity of the mutant with AT by 1 order of magnitude specifically in the presence H5. To understand the mechanism by which heparin activation of AT improves the reactivity of the serpin with fXa, the H5-catalyzed reaction of AT with fXa, fXa R150A, and fXa S195A was studied using rapid kinetic, surface plasmon resonance, and competitive binding methods. The pseudo-first-order rate constants for the H5-catalyzed AT inhibition of both fXa and fXa R150A exhibited a linear dependence on the serpin concentration, thereby yielding second-order rate constants of 1.0 x 10(6) and 1.5 x 10(5) M(-)(1) s(-)(1), respectively. On the other hand, an approximately 70-saccharide, high-affinity heparin-catalyzed AT inhibition of both fXa derivatives showed a saturable dependence on the inhibitor concentration, yielding an identical rate constant of approximately 20 s(-)(1), but different ternary fXa-heparin-AT dissociation constants (K(E,ATH)) of approximately 130 and approximately 1780 nM for wild-type and R150A fXa, respectively. Competitive kinetic and surface plasmon resonance binding studies using the catalytically inactive S195A mutant of fXa yielded dissociation constants of 255 and 610 nM, respectively, for the mutant protease interaction with the AT-H5 complex. These results suggest that H5 enhances the reactivity of AT with fXa primarily by lowering the K(E,ATH) for the formation of a Michaelis-type serpin-protease encounter complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618121      PMCID: PMC2538365          DOI: 10.1021/bi060056r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

Review 1.  Serpin structure, mechanism, and function.

Authors:  Peter G W Gettins
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.

Authors:  A R Rezaie
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 3.  New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jeffrey I Weitz; Jack Hirsh; Meyer M Samama
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

4.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

5.  Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.

Authors:  S T Olson; J D Shore
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

6.  Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.

Authors:  S T Olson; R Swanson; D Day; I Verhamme; J Kvassman; J D Shore
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

7.  Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.

Authors:  A R Rezaie; S T Olson
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

8.  Role of basic residues of the autolysis loop in the catalytic function of factor Xa.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

9.  Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2004-06-03       Impact factor: 22.113

10.  Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.

Authors:  Steven T Olson; Richard Swanson; Elke Raub-Segall; Tina Bedsted; Morvardi Sadri; Maurice Petitou; Jean-Pascal Hérault; Jean-Marc Herbert; Ingemar Björk
Journal:  Thromb Haemost       Date:  2004-11       Impact factor: 5.249

View more
  4 in total

1.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

2.  Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.

Authors:  Gonzalo Izaguirre; Alireza R Rezaie; Steven T Olson
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

3.  Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition.

Authors:  Patrick R Gonzales; Timothy D Walston; Laureano O Camacho; Dana M Kielar; Frank C Church; Alireza R Rezaie; Scott T Cooper
Journal:  Biochim Biophys Acta       Date:  2007-08-30

Review 4.  Serpins in plants and green algae.

Authors:  Thomas H Roberts; Jørn Hejgaard
Journal:  Funct Integr Genomics       Date:  2007-11-06       Impact factor: 3.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.